Effectiveness of Micropulse Transscleral Laser Therapy in Uncontrolled Glaucoma Secondary to Ciliary Body Metastasis

Overview

Journal Am J Ophthalmol Case Rep

Specialty Ophthalmology

Date 2021 Aug 19

PMID 34409197

Authors

Pukkapol Suvannachart

Patcharaporn Jaru-Ampornpan

Sunee Chansangpetch

Anita Manassakorn

Visanee Tantisevi

Kitiya Ratanawongphaibul

Affiliations

Soon will be listed here.

Abstract

Purpose: To report a case of ciliary body metastasis with uncontrolled glaucoma that was successfully treated with micropulse transscleral laser therapy (MPTLT).

Observations: A case of a 44-year-old female with uncontrolled glaucoma secondary to ciliary body metastasis from pulmonary adenocarcinoma. Antiglaucoma medications, intravitreal ranibizumab injection and local radiotherapy were ineffective in reducing her intraocular pressure (IOP) and ocular pain. MPTLT using a power setting of 2,000 mW, 31.3% duty cycle, and 140 seconds over 180 degrees demonstrated favorable IOP reduction (from 31 to 8 mmHg) on the first postoperative day without either ocular pain or postoperative complications. IOP remained controlled until she died from hemoperitoneum 18 days after hospital discharge.

Conclusions And Importance: MPTLT can be a safe and effective procedure for IOP control in intraocular metastasis patients with uncontrolled glaucoma.

References

Shields C, Shields J, Shields M, Augsburger J . Prevalence and mechanisms of secondary intraocular pressure elevation in eyes with intraocular tumors. Ophthalmology. 1987; 94(7):839-46. DOI: 10.1016/s0161-6420(87)33537-7. View

Nguyen A, Maslin J, Noecker R . Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma. Eur J Ophthalmol. 2019; 30(4):700-705. DOI: 10.1177/1120672119839303. View

Thulliez M, Angoulvant D, Le Lez M, Jonville-Bera A, Pisella P, Gueyffier F . Cardiovascular events and bleeding risk associated with intravitreal antivascular endothelial growth factor monoclonal antibodies: systematic review and meta-analysis. JAMA Ophthalmol. 2014; 132(11):1317-26. DOI: 10.1001/jamaophthalmol.2014.2333. View

Shields C, Welch R, Malik K, Acaba-Berrocal L, Selzer E, Newman J . Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin. Middle East Afr J Ophthalmol. 2018; 25(2):81-90. PMC: 6071342. DOI: 10.4103/meajo.MEAJO_6_18. View

Camp D, Yadav P, Dalvin L, Shields C . Glaucoma secondary to intraocular tumors: mechanisms and management. Curr Opin Ophthalmol. 2018; 30(2):71-81. DOI: 10.1097/ICU.0000000000000550. View

Groenewald C, Konstantinidis L, Damato B . Effects of radiotherapy on uveal melanomas and adjacent tissues. Eye (Lond). 2012; 27(2):163-71. PMC: 3574249. DOI: 10.1038/eye.2012.249. View

Nakashima C, Keino H, Watanabe T, Taki W, Okada A . Intravitreal bevacizumab for iris metastasis of small-cell lung carcinoma with neovascular glaucoma. Jpn J Ophthalmol. 2011; 55(1):80-1. DOI: 10.1007/s10384-010-0892-z. View

Makri O, Psachoulia C, Exarchou A, Georgakopoulos C . Intravitreal Ranibizumab as Palliative Therapy for Iris Metastasis Complicated With Refractory Secondary Glaucoma. J Glaucoma. 2014; 25(1):e53-5. DOI: 10.1097/IJG.0000000000000163. View

Freedman M, Folk J . Metastatic tumors to the eye and orbit. Patient survival and clinical characteristics. Arch Ophthalmol. 1987; 105(9):1215-9. DOI: 10.1001/archopht.1987.01060090073031. View

10.

Hidaka T, Chuman H, Nao-I N . A Case Report of Intravitreal Bevacizumab for Iris Metastasis of Small Cell Lung Carcinoma with Neovascular Glaucoma. Case Rep Ophthalmol. 2018; 9(2):401-404. PMC: 6167676. DOI: 10.1159/000492713. View

11.

Varikuti V, Shah P, Rai O, Chaves A, Miranda A, Lim B . Outcomes of Micropulse Transscleral Cyclophotocoagulation in Eyes With Good Central Vision. J Glaucoma. 2019; 28(10):901-905. DOI: 10.1097/IJG.0000000000001339. View

12.

Shukla A, Vaidya S, Yaghy A, Razeghinejad R, Mantravadi A, Myers J . Transscleral Cyclophotocoagulation for Glaucoma in the Setting of Uveal Melanoma. Ophthalmol Glaucoma. 2020; . DOI: 10.1016/j.ogla.2020.09.011. View

13.

Kellaway J, Feldman R . Semiconductor diode laser transscleral cyclophotocoagulation in a patient with glaucoma secondary to metastatic tumor to the iris. J Glaucoma. 1998; 7(5):317-8. View

14.

Aquino M, Barton K, Tan A, Sng C, Li X, Loon S . Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Exp Ophthalmol. 2014; 43(1):40-6. DOI: 10.1111/ceo.12360. View

15.

Kaliki S, Eagle R, Grossniklaus H, Campbell R, Shields C, Shields J . Inadvertent implantation of aqueous tube shunts in glaucomatous eyes with unrecognized intraocular neoplasms: report of 5 cases. JAMA Ophthalmol. 2013; 131(7):925-8. DOI: 10.1001/jamaophthalmol.2013.828. View

16.

Sanchez F, Lerner F, Sampaolesi J, Noecker R, Becerra N, Iribarren G . Efficacy and Safety of Micropulse® Transscleral Cyclophotocoagulation in Glaucoma. Arch Soc Esp Oftalmol (Engl Ed). 2018; 93(12):573-579. DOI: 10.1016/j.oftal.2018.08.003. View

17.

Valent Jr D, Augsburger J, Correa Z . Embyronal carcinoma of testis metastatic to ciliary body presenting as spontaneous hyphema and painful secondary glaucoma. Retin Cases Brief Rep. 2014; 7(1):105-7. DOI: 10.1097/ICB.0b013e318275380b. View

18.

Chen M, Liu J, Li W, Lee F, Chou C, Hsu W . Diode laser transscleral cyclophotocoagulation in the treatment of refractory glaucoma with iris melanocytoma. J Chin Med Assoc. 2008; 71(10):546-8. DOI: 10.1016/S1726-4901(08)70166-7. View

19.

Lampaki S, Kioumis I, Pitsiou G, Lazaridis G, Syrigos K, Trakada G . Lung cancer and eye metastases. Med Hypothesis Discov Innov Ophthalmol. 2015; 3(2):40-4. PMC: 4346676. View

20.

Sanchez F, Peirano-Bonomi J, Grippo T . Micropulse Transscleral Cyclophotocoagulation: A Hypothesis for the Ideal Parameters. Med Hypothesis Discov Innov Ophthalmol. 2018; 7(3):94-100. PMC: 6205680. View